Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial    crawled time : 16:20    save search
SMART trial one-year data demonstrates Medtronic Evolut™ TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women
Published: 2024-04-07 (Crawled : 16:20) - prnewswire.com
MDT | $81.29 0.89% 0.0% 5.2M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
EW | $87.75 0.91% 0.0% 2.7M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
treatment for women smart trial platform
EVVTY DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Evolution AB (publ) Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action - EVVTY
Published: 2024-03-24 (Crawled : 16:20) - prnewswire.com
BCDRF | $4.978 -8.71% 100 twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
SAN | $4.99 2.68% -0.2% 11M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages New York Community Bancorp, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NYCB
Published: 2024-03-02 (Crawled : 16:20) - prnewswire.com
MBLY | $30.41 0.96% 0.95% 1.6M twitter stocktwits trandingview |
| Email alert Add to watchlist
CART 4 | $33.41 -7.43% -8.02% 8.9M twitter stocktwits trandingview |
| Email alert Add to watchlist
SBNY | News | $3.5 0.0% 250K twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
UNTY | $27.53 0.07% 0.04% 7.2K twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
NYCB | $3.18 1.92% -0.31% 13M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Dada Nexus Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important March 11 Deadline in Securities Class Action First Filed by the Firm - DADA
Published: 2024-02-25 (Crawled : 16:20) - prnewswire.com
DADA | News | $1.865 -1.84% -1.88% 1.6M twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
EAF | $1.57 -1.88% 0.0% 2M twitter stocktwits trandingview |
Producer Manufacturing
 | Email alert Add to watchlist
first deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Driven Brands Holdings Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DRVN
Published: 2024-01-28 (Crawled : 16:20) - prnewswire.com
ADM | $61.79 -1.14% 0.0% 3.2M twitter stocktwits trandingview |
Process Industries
 | Email alert Add to watchlist
DRVN | $15.045 4.41% 4.22% 1.3M twitter stocktwits trandingview |
| Email alert Add to watchlist
CHPT 4 | $1.34 -1.47% 0.0% 13M twitter stocktwits trandingview |
| Email alert Add to watchlist
brands deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Microvast Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - MVST, MVSTW
Published: 2023-12-31 (Crawled : 16:20) - prnewswire.com
BCLI A | $0.531 -1.69% -1.71% 170K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
MIST | $1.67 2.45% 2.4% 90K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Fisker Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FSR
Published: 2023-12-16 (Crawled : 16:20) - prnewswire.com
FMC A | $58.65 0.69% 0.0% 1.6M twitter stocktwits trandingview |
Process Industries
 | Email alert Add to watchlist
FSR | $0.0896 0.0% 62M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
EH | $17.315 1.85% 1.82% 840K twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
deadline trial
DCGO DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages DocGo Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - DCGO
Published: 2023-12-16 (Crawled : 16:20) - prnewswire.com
FSR | $0.0896 0.0% 62M twitter stocktwits trandingview |
Finance
 | Email alert Add to watchlist
EH | $17.315 1.85% 1.82% 840K twitter stocktwits trandingview |
Technology Services
 | Email alert Add to watchlist
DCGO | $3.505 -0.14% -0.14% 570K twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline trial
Long-term Survival Data from Longeveron’s ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association
Published: 2023-11-11 (Crawled : 16:20) - globenewswire.com
LGVN 4 d | $1.79 -4.28% -4.47% 270K twitter stocktwits trandingview |
| Email alert Add to watchlist
association sessions heart trial
Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023
Published: 2023-11-11 (Crawled : 16:20) - globenewswire.com
ESPR | $2.08 8.9% 8.17% 4.9M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
disease association care heart trial
Groundbreaking EV-302 Trial Significantly Extends Overall Survival and Progression-Free Survival in Patients Treated with PADCEV® (enfortumab vedotin-ejfv) and KEYTRUDA® (pembrolizumab) in First-Line Advanced Bladder Cancer
Published: 2023-10-22 (Crawled : 16:20) - prnewswire.com
ALPMF | News | $9.75 43.47% 200 twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SGEN | $228.74 0.1% 20M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
ALPMY | News | $9.53 -1.11% 690K twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
ev-302 padcev bladder cancer trial
TIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged Overall Survival in Patients with Recurrent or Metastatic Cervical Cancer Compared with Chemotherapy in Global Phase 3 innovaTV 301 Trial
Published: 2023-10-22 (Crawled : 16:20) - globenewswire.com
GMAB | News | $28.54 -1.48% -1.51% 560K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
SGEN | $228.74 0.1% 20M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
GNMSF | News | $289.67 3.83% 5.3K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
tivdak cancer global trial
Immunocore presents three-year overall survival data from the KIMMTRAK Phase 3 trial
Published: 2023-10-21 (Crawled : 16:20) - globenewswire.com
IMCR | $57.32 2.69% 2.62% 300K twitter stocktwits trandingview |
Manufacturing
 | Email alert Add to watchlist
kimmtrak trial
Harpoon Therapeutics Announces Updated Interim Tolerability and Response Data from Phase 1/2 Clinical Trial of T Cell Engager HPN328 at ESMO Congress 2023
Published: 2023-10-21 (Crawled : 16:20) - globenewswire.com
HARP | $23.01 0.07% 6.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
hpn328 congress cell trial therapeutics response
Annexon Presents ARCHER Trial Results at ASRS 2023 Highlighting Potential of ANX007 as a Differentiated Treatment for Geographic Atrophy
Published: 2023-07-30 (Crawled : 16:20) - globenewswire.com
ANNX | $4.46 -1.87% -1.91% 800K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
anx007 treatment trial potential results
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
Published: 2023-07-29 (Crawled : 16:20) - prnewswire.com
BTAI | News | $2.965 4.04% 3.88% 410K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BAX | $41.02 1.54% 0.0% 2.6M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
BHC | $8.53 0.95% 0.0% 4M twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
international deadline trial
4DMT Presents Additional Positive Interim Data from Intravitreal 4D-150 Phase 1/2 PRISM Clinical Trial in Patients with Wet AMD at ASRS 2023
Published: 2023-07-29 (Crawled : 16:20) - globenewswire.com
FDMT M | $24.77 -6.14% -6.54% 570K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
prism positive trial
Zealand Pharma Presents Results from Phase 1 Clinical Trial of Amylin Analog ZP8396 at ADA Scientific Sessions
Published: 2023-06-24 (Crawled : 16:20) - globenewswire.com
ZEAL | $17.59 1.21% -4.21% twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
zp8396 pharma sessions trial results
Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress
Published: 2023-06-17 (Crawled : 16:20) - globenewswire.com
VERA | $39.46 0.84% 0.84% 1.2M twitter stocktwits trandingview |
Professional, Scientific, and T...
 | Email alert Add to watchlist
association renal presentation origin positive week trial therapeutics results igan
NewAmsterdam Pharma Presents Full Data from Phase 2 ROSE2 Trial Evaluating Obicetrapib in Combination with Ezetimibe as an Adjunct to High-Intensity Statin Therapy at NLA Scientific Sessions 2023
Published: 2023-06-03 (Crawled : 16:20) - globenewswire.com
NAMS | $21.5 6.28% 5.91% 170K twitter stocktwits trandingview |
n/a
 | Email alert Add to watchlist
pharma sessions trial therapy
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance
EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance
SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.